Study to Evaluate Safety and Efficacy of Inhaled Bimosiamose for the Treatment of Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

A Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease

NCT06154837 ·Status: RECRUITING ·Phase: PHASE1

Safety, Tolerability and Pharmacokinetics and Effect on Inflammation of Oral BI 1026706 in Patients With COPD

NCT02642614 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT07292714 ·Status: RECRUITING ·Phase: PHASE2

A Study to Evaluate the Effectiveness and Safety of CNTO6785 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

NCT01966549 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study of Losmapimod (GW856553) in Frequently Exacerbating Participants With Chronic Obstructive Pulmonary Disease (COPD)

NCT02299375 ·Status: COMPLETED ·Phase: PHASE2

Safety, Toleration and Efficacy of Single Inhaled Doses of PF-00610355 in Chronic Obstructive Pulmonary (COPD) Patients.

NCT00783406 ·Status: COMPLETED ·Phase: PHASE2

A 7-Day Cross-over Study of QD (Once Daily) and BID (Twice Daily) TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)

NCT02109172 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Dose-Response Relationship of Multiple Doses of GSK2269557 Administered as a Dry Powder to Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT02130635 ·Status: COMPLETED ·Phase: PHASE2

Investigation of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of Oral Danirixin in Symptomatic COPD Subjects With Mild to Moderate Airflow Limitation at Risk for Exacerbations

NCT02130193 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Pharmacokinetic Characteristics, Safety, Tolerability, and Preliminary Efficacy of 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD).

NCT06175351 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Study to Evaluate Safety, Tolerability and Pharmacokinetics of Multiple Rising of BEA 2180 BR in Japanese Healthy Male Volunteers

NCT02254109 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

NCT02546700 ·Status: COMPLETED ·Phase: PHASE2

Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide

NCT01543919 ·Status: COMPLETED ·Phase: PHASE2

An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

NCT01867762 ·Status: COMPLETED ·Phase: PHASE2

GSK573719 Dose Ranging Study in Chronic Obstructive Pulmonary Disease

NCT00950807 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety Study of Two Fixed-dose Combinations of Aclidinium Bromide With Formoterol Fumarate Compared With Aclidinium Bromide, Formoterol Fumarate and Placebo

NCT01049360 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Study to Evaluate the Efficacy and Safety of TQC2938 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

NCT06789289 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Efficacy of AZD3199 in Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT00929708 ·Status: COMPLETED ·Phase: PHASE2

A Multi-center Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of R7103 Following Repeated Inhalation in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease

NCT01009424 ·Status: WITHDRAWN ·Phase: PHASE1

A Study to Assess the Effect of CK-2127107 on Physical Function in Subjects With Chronic Obstructive Pulmonary Disease

NCT02662582 ·Status: COMPLETED ·Phase: PHASE2

A Phase II, Study To Evaluate The Efficacy And Safety Of PH-797804 In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD).

NCT00559910 ·Status: COMPLETED ·Phase: PHASE2

An Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler.

NCT00528996 ·Status: COMPLETED ·Phase: PHASE2

Treatment of Chronic Obstructive Pulmonary Disease by Infusion of Allogenic Mesenchymal Stem Cells

NCT06491043 ·Status: RECRUITING ·Phase: PHASE2

Dose Finding Study in COPD

NCT00122434 ·Status: COMPLETED ·Phase: PHASE2

A Study to Investigate GB-0895 in Adults With Mild to Moderate Asthma or COPD

NCT07116889 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1